Polymorphonuclear leukocytes and mononuclear phagocytes are both derived from bone marrow cells and follow a joined differentiation pathway separating rather late into independent cell lineages. The bifurcation and the final bipotent cell are ill defined, particularly so, since properties of both cell types are still mutually expressed beyond this point (1) . We previously isolated two calcium-binding proteins (MRP8 1 and MRP14), members of the S-100 protein family, expressed by polymorphonuclear leukocytes continuously and by a subset of blood monocytes, intruding acute inflammatory sites at a very early stage (2) (3) (4) .
While monocytes mature to macrophages, MRP8 and MRP14 expression is down-regulated and is completely absent from mature tissue macrophages (5, 6) . In blood monocytes, MRP8 and MRP14 are found in the cytoplasm and rapidly translocated to the plasma membrane and the cytoskeleton when intracellular calcium levels are raised (7) (8) (9) .
MRP8 and MRP14 form homo-and heterodimers in the presence of Ca 2ϩ (10, 11) ; bind arachidonic acid, a metabolite of the prostaglandine pathway in a strictly calcium-dependent manner (10, 12) ; and may be secreted by a novel protein kinase C-and tubulin-dependent pathway (13) . Although the surface expression of the heterodimer correlates well with increased secretion of TNF␣ and IL1␤ (14) , little is known about the function of MRPs. MRPs are involved in cell cycle progression, cell differentiation, cytoskeleton-membrane interaction, and phosphorylation events. Furthermore, antifungal, antibacterial, and chemotactic functions have been described (for a review see Refs. [15] [16] [17] [18] . Consequently, the proteins are found to be elevated in patients with acute and chronic inflammatory diseases, such as inflammatory bowel diseases and rheumatoid arthritis (19, 20) . MRP8 and MRP14 have been suggested as new sensitive markers for the different stages of HIV disease (21) .
Besides the functional importance, the regulation of the MRP promoter is of particular interest for a variety of reasons as follows.
Using the MRP promotors, new insights into mechanisms of gene expression in myeloid/monocytic are acquired, since the expression in noninflammatory tissue is absolutely restricted to these cells. The MRP promotors are highly effective in these cells; MRPs are highly expressed, up to 1% of the total proteins of monocytes and up to 45% of the total protein content of granulocytes (18) . MRP8 and MRP14 are expressed by the same cells in acute inflammation but by different cells in chronic inflammation (22, 23) , which enables us to find regulatory proteins. Finally, a relatively small portion of the MRP8 promoter (1 kilobase pair) is sufficient for lineage-specific expression as demonstrated in transgenic mice (24) .
Thus, the MRP promoters are specific for monocytes and granulocytes and also responsible for a high transcription rate. Furthermore, the regulatory elements important for lineagespecific expression are located within 1 kilobase pair of the promoter, opening the possibility of designing short constructs useful for cell-specific expression.
The promoter of MRP14 contains several putative protein binding sites, as derived from a computerized search using the "Transfec Matrix Table" (41) . Some of them are reported to predominate in the myeloid lineage (Fig. 1) . However, whether or not these transcription factors play a major role in regulating the expression of MRP14 needs to be determined experimentally.
We present evidence that part of the first intron of the MRP14 gene contains an enhancer element, which increases the transcriptional efficiency up to 37-fold when cloned to a heterologous promoter. This enhancing element is located between positions 153 and 192 of the gene as demonstrated in combination with the herpes simplex thymidine kinase promoter.
Additionally, we demonstrate that DNA-binding proteins interact specifically with the enhancer, and we could purify four proteins forming a complex with the enhancer. The sequence of this fragment shows high homology to elements at corresponding positions in the first intron of other MRPs (6, 25, 26) , 2 but no homology was found to binding sites of commonly known transcription factors.
EXPERIMENTAL PROCEDURES
Constructs-A human genomic library (Stratagene, La Jolla, CA) was screened by plaque hybridization using a 32 P-labeled DNA fragment generated by polymerase chain reaction. This fragment was amplified using human genomic DNA as template and the primers 5Ј-GGGGTTAGAAGGGTTCTCAG (position Ϫ520 of the MRP14 gene) and 5Ј-ATCACTGTGGAGTAGGGG (position Ϫ1000 of the MRP14 gene; Ref. 25) . From 6 ϫ 10 5 independent clones, three positive plaques were identified and purified. One clone containing approximately 7 kilobase pairs of the promoter was subcloned into the EcoRI site of the pSP72 cloning vector (Promega, Madison, WI) and further analyzed by restriction analysis and sequencing. The pCAT3-Basic vector (Promega) was used to test the MRP14 exon/intron I in combination with the homologous promoter.
The herpes simplex virus thymidine kinase promoter was purchased from CLONTECH (Palo Alto, CA) and subcloned into the pSP72 cloning vector (Promega).
To investigate the enhancing activity of the first exon/intron of the human MRP14 gene, the first exon and the first intron of the MRP14 gene were cloned adjacent to the herpes simplex virus thymidine kinase (TK) promoter (27) . An overview of the used constructs is shown in Fig.  4 : 1) the TK-promoter in the 5Ј-position of the MRP14 exon/intron (pTK14C), 2) the TK promoter in the 3Ј-position of the MRP14 exon/ intron (p14TKC), 3) the TK promoter 5Ј to the MRP14 exon/intron with a deletion of the HindIII-HindIII fragment covering positions 153-369 within the 1st intron (pTK14C⌬H), and 4) resubstitution of the HindIII fragment with a fragment of exactly the same size generated by polymerase chain reaction using pSP72 as template (pTK14C art ). To compare the different constructs, a reference plasmid was designed that expresses CAT only under TK promoter control (pTKC). Additionally, the region 153-192 of the MRP14 gene was cloned 5Ј to the TK promoter in pTKC (pE14TKC). To confirm the specificity of the DNA element, a mutated DNA fragment containing a NOT1 restriction site (GCGGC-CGC) instead of the sequence ACTTTCT was cloned 5Ј to the TK promoter in pTKC (pNot1TKC).
Cells and Culture-HL-60 cells (ATTC CCL240) and L132 (ATTC CCL5) were cultured using RPMI 1640 medium supplemented with 10% fetal bovine serum. L132 cells are embryonic lung fibroblasts that have been demonstrated to express neither MRP8 nor MRP14 (25) . HL-60 cells were treated with 1.25% Me 2 SO for 3 days to differentiate into granulocytic cells (28) and subsequently electroporated. Mono Mac 6 cells (DSM ACC 124) were cultured in RPMI 1640 medium containing 10% fetal bovine serum, 2 mM L-glutamine, 1% nonessential amino acids, 1 mM sodium pyruvic acid, and 9 g/ml bovine insulin (27) .
Electroporation and CAT Assay-Transfection was performed as described previously (30) . Briefly, 7 ϫ 10 6 cells were electroporated with 30 g of DNA, 960 microfarads at 290 V for HL-60 and 960 microfarads at 250 V for Mono Mac 6 cells and L132 fibroblasts using a gene pulser (Bio-Rad). After electroporation, the cells were incubated in the appropriate medium for 24 h at 37°C and 5% CO 2 . To analyze the transcriptional activity of the constructs, the activity of chloramphenicol acetyl transferase was determined by using [ Northern Blotting-Cells were extracted by a modification of the method of Chomzynski and Sacchi (32) using guanidinium thiocyanate/ phenol chloroform extraction to provide total RNA samples. Aliquots of the RNA (20 g) were separated on a denaturing 1.5% agarose gel, blotted onto nylon membrane, and probed with 32 P-labeled human MRP14 according to standard methods (31) . Finally, the membrane was washed twice with 0.1% SSC at 65°C and exposed to an x-ray film for 2 days.
EMSA-Nuclear protein extracts were obtained by using a micropreparation technique (33) . Briefly, 1 ϫ 10 7 cells were resuspended in buffer A (10 mM HEPES, 1.5 mM MgCl 2 , 10 mM KCl, 0.5 mM dithiothreitol, 0.2 mM phenylmethylsulfonyl fluoride, pH 7.9) and were allowed to swell for 10 min on ice. After brief centrifugation, the cell pellet was resuspended in cold buffer C (20 mM HEPES-KOH, 25% glycerol, 420 mM NaCl, 1.5 mM MgCl 2 , 0.2 mM EDTA, 0.5 mM dithiothreitol, 0.2 mM phenylmethylsulfonyl fluoride, pH 7.9) and incubated for 20 min on ice for high salt extraction. The nuclear proteins were further purified by centrifugation and subsequently snap-frozen in N 2 and stored at Ϫ70°C.
DNA fragments of interest were end-labeled with [␥-32 P]ATP using T4 polynucleotide kinase or with [␣-32 P]CTP using Klenow fragment. The assay was performed as described with minor adaptations (34) . Briefly, 10 g of nuclear protein were incubated with 1 ng of radiolabeled DNA in 15 l of binding buffer (0.56 mg/ml salmon sperm DNA, 300 g/ml bovine serum albumin in 12 mM HEPES, 12% glycerol, 4 mM Tris, 120 mM NaCl, 1 mM EDTA, 1 mM dithiothreitol, pH 7.9) and incubated for 30 min at 30°C. After electrophoresis using 6 or 8% polyacrylamide gels, the shifted DNA fragments were visualized by autoradiography.
DNA Cross-linking-Using 32 P-labeled bromine/uridine-modified oligonucleotides (positions 153-177), DNA-protein UV cross-linking was performed. After incubation of the DNA with nuclear protein under the same conditions as for EMSA analysis, the reactions were subjected to UV cross-linking (3000 microwatts/cm 2 , Crosslinker 1800; Stratagene) for 15 min at 4°C. This reaction was analyzed by 10% SDS-polyacrylamide gel electrophoresis and subsequent autoradiography.
Southwestern Analysis-Southwestern analysis was performed as described by Chen et al. (35) with minor adaptations. Nuclear protein extracts were separated by SDS-polyacrylamide gel electrophoresis using 15% acrylamide under standard conditions. The proteins were transferred to a nitrocellulose filter (Schleicher and Schü ll, Dassel, Germany) and subsequently renatured in buffer A (10 mM Tris, 1 mM EDTA, 50 mM NaCl, 0.1% Triton X-100, 0.3% bovine serum albumin, 2 W. Nacken, unpublished observations. Table (41). 0.02% Ficoll 400, and 0.02% polyvinylpyrolidone). Prehybridization was performed in buffer A supplemented with 5% milk powder for 1 h at room temperature. For hybridization, 5 g/ml salmon sperm DNA and the 32 P-labeled probe described above in a concentration of 10 4 -10 5 cpm/ml were added to the prehybridization mixture. The filters were washed twice for 15 min in buffer A at room temperature and subsequently autoradiographed at Ϫ70°C for visualization of the DNA-protein interaction. Affinity Purification-Biotin-labeled oligonucleotides were purchased from Eurogentec (Seraing, Belgium) and bound to streptavidin magnetic beads (Merck, Darmstadt, Germany) following the manufacturer's instructions. Nuclear protein extract from Mono Mac 6 cells and the oligonucleotide-coupled magnetic beads were incubated in EMSAbinding buffer for 2 h at room temperature. Subsequently, the beads were washed with 20 mM Hepes buffer, pH 7.6, supplemented with increasing concentrations of NaCl as indicated in Fig. 10 . The obtained proteins were analyzed using SDS-polyacrylamide gel electrophoresis (31) .
RESULTS

MRP14 mRNA Expression in Mono Mac 6
Cells-Total cellular RNA was extracted from Mono Mac 6 cells and analyzed by Northern blot analysis using human MRP14 cDNA as probe (Fig. 2) . Unstimulated HL-60 cells and Me 2 SO-treated HL-60 cells were analyzed on the same blot. No MRP14 mRNA could be detected in unstimulated HL-60 cells, whereas Me 2 SO-stimulated HL-60 cells expressed MRP14 mRNA. Nonstimulated Mono Mac 6 cells expressed MRP14 mRNA to a slightly lesser extent than Me 2 SO-treated HL-60 cells (Fig. 2) .
Effects of the MRP14 Intron I on Transcription Using the MRP14 Promoter-The MRP14 promoter from position Ϫ1000 was cloned with or without the first exon/intron positioned 5Ј to the CAT gene (Fig. 3) . These constructs (pHM1.0TC3 with first exon/intron and pHM1.0EC3 lacking first exon/intron) were used to transfect HL-60 cells stimulated with 1.25% Me 2 SO and unstimulated Mono Mac 6 cells (Fig. 3) . In both cell lines, doubling of CAT activity was observed when the exon/intron 1 was present (Fig. 3) .
Effects of the MRP14 Intron I on Transcription Using a Heterologous Promoter-To distinguish whether the enhancing activity is dependent on the promoter or on the position of the enhancing elements with respect to the promoter, pTKCAT constructs were used to transfect Mono Mac 6 cells and human L132 embryonic fibroblasts. To compare the transcriptional activity resulting from 12-16 independent electroporations, all data are presented in relation to the CAT activity of the basic plasmid, pTKC, which contains the TK promoter and the CAT encoding sequence. The exon/intron I fragment of the MRP14 gene cloned in the 3Ј-position of the TK promoter (pTK14C) enhances the transcriptional rate 9.8-fold in Mono Mac 6 cells and 37-fold in L132 cells (Fig. 4) . Electroporation of Mono Mac 6 and L132 cells with a construct in which the position of the MRP14 exon/intron 1 lies 5Ј to the TK promoter (p14TKC) reveals that the transcriptional rate is increased 10. (Fig. 6) , while proteins from E. coli as negative control are not capable of inducing a gel shift. A total of five band shifts can be distinguished using electrophoresis mobility assay. These bands are seen in all cells investigated, although the absolute concentration of the different proteins appears to vary. EMSA analysis with the mutated 39 base fragment used in the transfection experiments (Fig. 5) revealed that the mutated fragment was unable to bind proteins in L132 or Mono Mac 6 cells (NotI, Fig.  7) .
To further investigate the binding protein, the Southwestern technique was employed. The blotted nuclear protein cells (Mono Mac 6, HL-60, HL-60 Me 2 SO, and L132 fibroblasts) were incubated with the labeled 39-base fragment (positions 153-192 of the MRP14 gene). As presented in Fig. 8 , several proteins that bind under these conditions to the DNA can be distinguished; two proteins predominate that migrate corresponding to a size of 38 kDa. These proteins are visible in all tested cells, although the expression is comparably low in L132 fibroblasts. One protein is present in higher quantities in all nuclear protein extracts corresponding to a molecular mass of 65 kDa. Another protein of 50 kDa can be detected in faint amounts. Proteins of E. coli do not bind at all to the DNA used in these experiments.
Using UV DNA cross-linking, two interacting proteins are visible in all cells under investigation. These proteins migrate at 35 and 38 kDa (Fig. 9) . A further band is observable at 45 kDa in Mono Mac 6 monocytes and L132 fibroblasts.
As indicated in Fig. 9 , affinity purification of Mono Mac 6 monocytes using the DNA fragment from 153 to 192 of the MRP14 gene results in four proteins that elute at 250 mM NaCl. These proteins remain bound to the DNA at NaCl concentrations of 220 mM, at which nonspecifically binding proteins are rapidly eluted. Higher NaCl concentrations (500 mM) elute no further proteins from the DNA.
DISCUSSION
In this report, we investigated the expression of MRP14 in myeloid/monocytic cells using promoter constructs containing or lacking the first intron of the MRP14 gene. Our experiments revealed a strong enhancer element within the first intron, which is localized between positions 153 and 192 of the MRP14 gene. Furthermore, we found four proteins that specifically bind the enhancer element. Together, these proteins in combination with the enhancer element contribute to the high expression of MRP in monocytes and granulocytes (18) , while the cell type-specific elements need to be determined.
Functional analysis of the regulation of MRP14 expression in myeloid/monocytic cells made it necessary to select cell lines reflecting the pattern of MRP14 expression in granulocytes and monocytes. The expression of MRP8 and MRP14 in Me 2 SOstimulated HL-60 cells, which represent granulocytes (28) has been demonstrated previously (36) . In this study, we showed that Mono Mac 6 cells also express MRP14 in sufficient amounts to perform transfection experiments (Fig. 2) . Therefore, Mono Mac 6 cells were chosen as a useful model to study MRP14 gene regulation, particularly in terms of its monocytic characteristics (29) .
The MRP14 gene contains three exons, and the translation start site is localized at position 430 in exon 2 ( Fig. 1 (25) ). We present evidence that cells transfected with constructs containing the entire first intron showed significantly higher CAT activity compared with those cells that are transfected with constructs containing only the 5Ј-regulatory region of the MRP 14 gene (Fig. 3) . We conclude that there must be an enhancing element in the first intron. According to the definitions (37), the DNA element found here is an enhancer; it works well in a heterogeneous promoter (pTK14C; Fig. 4) , and it functions independently of the position (p14TKC; Fig. 4 ). In addition to the deletion and the substitution experiment (pTK14C⌬H, pTK14C art ) a short 39-base fragment was cloned adjacent to the thymidine kinase promoter (pE14TKC). The strong enhancing effect was observable in both the Mono Mac 6 monocytes and the L132 fibroblasts (Fig. 5) . Therefore, the enhancer is localized in the region between positions 153 and 192 of the MRP14 gene. Substitution of the MRP element (EL1) with a mutant DNA fragment (NotI) demonstrates the sequence of the enhancer EL1 (ACTTTTCT). The mutated DNA was neither able to induce a gel shift (Fig. 7) nor able to enhance the TK promoter (Fig. 5) .
The location of enhancers within introns has been reported for various genes (38) . It is of particular interest that genes expressed in blood cells i.e. immunoglobulin , mts-1, interleukin-4, interferon-␥, or eosinophil-derived neurotoxin genes are frequently reported to contain intron enhancers (39, 40, 52, 53) . Some of these enhancers are cell-specific like the enhancers in the interferon-␥ (53) or the interleukin-4 gene (52). Other enhancers like the -B site in the mts-1 gene exhibit their enhancing activity even in cells where the gene is not expressed, as has been demonstrated here. It might be useful to investigate whether blood cell-specific genes use intron-located enhancers to regulate gene expression.
The enhancer described here is obviously more potent in combination with the TK promoter than in combination with the MRP14 promoter (Figs. 3-5) . This is probably due to the basal activity of the promoters; while the TK promoter is known to be moderately efficient, the MRP14 promoter in myeloid cells is as strong as the cytomegalovirus promoter. There- fore, using the MRP14 promoter, the transcription machinery of the cell is maximal active, whereas there is more potential for increase of the transcription rate with the TK promoter.
On the basis of EMSA, Southwestern blot, DNA cross-linking, and affinity purification experiments, we were able to show that the enhancer binds several proteins, which are expressed in Mono Mac 6, in L132 fibroblasts, and in HL-60 cells with and without Me 2 SO stimulation (Figs. 6 -10) . The fact that we found the same patterns of proteins, as shown by the molecular weights, by a variety of different techniques demonstrates that our findings are sound. Furthermore, the abundance of these proteins correlates well with the activity of the enhancer in cell lines tested here (Mono Mac 6, L132, and HL-60 Me 2 SO; see Fig. 3 -5 (data for HL-60 without stimulation not shown)). Therefore, the proposed enhancer is not limited to specific cell lines but is potent in all tested cells.
Homology analysis of the first intron of both human and mouse MRP8 and MRP14 allows us to define the binding element as a DNA sequence with considerable homology in the different MRP genes (Fig. 11) . The core sequence of 8 nucleotides is found in all MRP genes at nearly identical positions at the beginning of intron 1, and this sequence is part of the 39 bases that are substantial enough to enhance the transcriptional rate. Further investigations will prove whether this element is involved in the regulation of the gene expression of all MRPs.
Data bank analysis using the DNA sequence of this element reveals that it can be found in at least two other genes. The murine BOX DNA contains this sequence 5Ј to the transcription start site (43) . It is proposed that the BOX is responsible for enhanced gene expression in embryonic cells. The enhancing activity is decreased upon further differentiation (43) , a feature that has been reported for the MRP expression in monocytes (5, 36, 44) . Additionally, this proposed enhancer can be found in the intron B of the glucophorin E gene (45) , which is mainly expressed in an erythroid-specific manner. To date, the available information is insufficient to decide whether or not the element described plays an important role in the expression of these genes. Nonetheless, this element is obviously present in genes that are expressed in undifferentiated hematopoietic cells. It is tempting to speculate that it is predominantly involved in undifferentiated blood cells like early monocytes.
The enhancer element described here could be used to increase the transcriptional activity of weak but otherwise very cell-specific promoters. The shortness of the element enhances the opportunity to express desired proteins under the control of cell-specific promotors at high levels. However, further investigations are necessary to confirm or disprove the theory that the cell specificity of any promoter is not affected by the element described. After the oligonucleotide was bound to magnetic beads, the Mono Mac 6 nuclear protein extract was added in the presence of increasing NaCl concentrations as indicated. SDS-polyacrylamide gel electrophoresis (10%) of the proteins obtained from the affinity column was performed. Elution with 0.22 M NaCl represents mainly nonspecific binding, whereas at 0.25 M NaCl four proteins with molecular masses of 32, 35, 38, and 45 kDa elute from the column. The elution apparently is specific, since no further proteins are eluted at higher NaCl concentrations.
